Long-Term Complications of Infectious Diseases in Children: Immune, Neurological, and Metabolic Aspects. Literature Review

Skryabina A. A.
Assistant, Chair for Infectious Diseases and Epidemiology, Faculty of Medicine

Mavudzi J. N.
Student, Faculty of Medicine

Ogunyuomi O. R.
Student, Faculty of Medicine

Pirogov Russian National Research Medical University, Moscow, Russian Federation

Skryabina Anna Aleksandrovna; e-mail: anna.skryabina.85@mail.ru

The study had no sponsorship.

None declared.

Infectious diseases in children, despite the successes of vaccination programs, continue to pose a significant problem for global public health, leading to the development of serious long-term consequences. This article reviews the general mechanisms behind such complications, including immune dysregulation, neurocognitive and mental disorders, metabolic and endocrine disturbances. It also provides a detailed analysis of the long-term sequelae of measles, polio, Epstein-Barr virus (EBV), and COVID-19 (SARS-CoV-2). Special attention is paid to the phenomena of immunological amnesia, molecular mimicry, and chronic inflammation as key links in the pathogenesis. The significant disparities in infection rates and outcomes between countries with different income levels are highlighted, along with the socioeconomic factors that exacerbate the situation in resource-limited regions. The article reviews modern approaches to mitigating the chronic consequences of past infections, including expanding vaccination coverage, early diagnosis, telemedicine technologies, and comprehensive rehabilitation measures. Promising research directions are identified, such as the development of predictive biomarkers and the integration of international efforts to address existing global inequities in pediatric healthcare. The authors emphasize the need to shift from simply preventing acute infections to forming a systemic approach aimed at preserving children's health in the long term. It is underscored that insufficient attention to the long-term complications of infectious diseases in children significantly increases the medical, social, and economic costs to society. Evidence is also presented that adequate preventive and therapeutic measures can substantially reduce the risk of chronic complications and improve the quality of life for patients who suffered from infectious diseases in early childhood.

infectious diseases, child, vaccination, autoimmune diseases, neurocognitive disorders, Epstein-Barr virus infections, COVID-19

10.29234/2308-9113-2025-13-3-76-98

1. World Health Organization. Global Health Estimates 2020: Deaths by cause, age, sex, by country and region, 2000–2019. Geneva, World Health Organization; 2020. Available at: https://www.who.int/data/gho/data/themes/mortality-and-global-health-estimates/ghe-leading-causes-of-death

2. United Nations Inter-Agency Group for Child Mortality Estimation (UNIGME), Levels & Trends in Child Mortality: Report 2023, Estimates developed by the United Nations Inter-Agency Group for Child Mortality Estimation, United Nations Children’s Fund, New York, 2024. ISBN: 978-92-806-5542-1.

3. GBD 2021 Causes of Death Collaborators. Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990-2021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet 2024; 403 (10440): 2100-2132, doi: 10.1016/S0140-6736(24)00367-2

4. Mina M.J., Metcalf C.J.E., de Swart R.L., Osterhaus A.D.M.E., Grenfell B.T. Long-term measles-induced immunomodulation increases overall infectious disease mortality. Science 2015; 348(6235): 694-699, doi: 10.1126/science.aaa3662

5. Lanz T.V., Brewer R.C., Ho P.P., Moon J.S., Jude K.M., et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 2022; 603(7900): 321-327, doi: 10.1038/s41586-022-04432-7

6. Khandaker G.M., Zimbron J., Lewis G., Jones P.B. Prenatal maternal infection, neurodevelopment, and adult schizophrenia: A systematic review of population-based studies. Psychol Med. 2013; 43(2): 239-257, doi: 10.1017/S0033291712000736

7. Buonsenso D., Di Gennaro L., De Rose C., Morello R., D’Ilario F., et al. Long-term outcomes of pediatric infections: from traditional infectious diseases to long Covid. Future Microbiol. 2022; 17: 551-571, doi: 10.2217/fmb-2022-0031

8. Davydova I.V. Otdalennye posledstvija respiratorno-sincitial'noj virusnoj infekcii, perenesennoj v rannem detskom vozraste. [Long-term consequences of respiratory syncytial virus infection in early childhood.]. Pediatrija. Zhurnal im. G.N. Speranskogo [Pediatrics. Journal named after G.N. Speransky] 2018; 97(6):156-161. (In Russ.)

9. Oyo-Ita A., Oduwole O., Arikpo D., Effa E.E., Esu E.B., et al. Interventions for improving coverage of childhood immunisation in low- and middle-income countries. Cochrane Database Syst Rev. 2023; 12(12): CD008145, doi: 10.1002/14651858.CD008145.pub4

10. Bloom D.E., Chen S., Kuhn M., McGovern M.E., Oxley L., et al. The economic burden of chronic diseases: Estimates and projections for China, Japan, and South Korea. J Econ Ageing. 2020; 17(10016), doi: 10.1016/j.jeoa.2018.09.002

11. Shattock A.J., Johnson H.C., Sim S.Y., Carter A., Lambach P., et al. Contribution of vaccination to improved survival and health: modelling 50 years of the Expanded Programme on Immunization. Lancet 2024 May; 403(10441): 2307-2316, doi: 10.1016/S0140-6736(24)00850-X

12. Medernach R.L., Logan L.K. The Growing Threat of Antibiotic Resistance in Children. Infect Dis Clin North Am. 2018; 32(1): 1-17, doi: 10.1016/j.idc.2017.11.001

13. Minta A.A., Ferrari M., Antoni S., Portnoy A., Sbarra A., et al. Progress Toward Regional Measles Elimination – Worldwide, 2000-2021. MMWR Morb Mortal Wkly Rep. 2022; 71(47): 1489-1495, doi: 10.15585/mmwr.mm7147a1

14. GBD 2016 Diarrhoeal Disease Collaborators. Estimates of the global, regional, and national morbidity, mortality, and aetiologies of diarrhoea in 195 countries: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Infect Dis. 2018; 18(11): 1211-1228, doi: 10.1016/S1473-3099(18)30362-1

15. Sarfo J.O., Amoadu M., Kordorwu P.Y., Adams A.K., Gyan T.B., et al. Malaria amongst children under five in sub-Saharan Africa: a scoping review of prevalence, risk factors and preventive interventions. Eur J Med Res. 2023; 28(1): 80, doi: 10.1186/s40001-023-01046-1

16. Patel M., Lee A.D., Clemmons N.S., Redd S.B., Poser S., et al. National Update on Measles Cases and Outbreaks – United States, January 1-October 1, 2019. MMWR Morb Mortal Wkly Rep. 2019; 68(40): 893-896, doi: 10.15585/mmwr.mm6840e2

17. Phadke V.K., Bednarczyk R.A., Omer S.B. Vaccine Refusal and Measles Outbreaks in the US. JAMA. 2020; 324(13): 1344-1345, doi: 10.1001/jama.2020.14828

18. Baker R.E., Park S.W., Yang W., Vecchi G.A., Metcalf C.J.E, et al. The impact of COVID-19 nonpharmaceutical interventions on the future dynamics of endemic infections. Proc Natl Acad Sci U S A. 2020; 117(48): 30547-30553, doi: 10.1073/pnas.2013182117

19. Bigouette J.P., Henderson E., Traoré M.A., Wassilak S.G.F, Jorba J., et al. Update on Vaccine-Derived Poliovirus Outbreaks – Worldwide, January 2021-December 2022. MMWR Morb Mortal Wkly Rep. 2023; 72(14): 366-371, doi: 10.15585/mmwr.mm7214a3

20. Rocklöv J., Dubrow R. Climate change: an enduring challenge for vector-borne disease prevention and control. Nat Immunol. 2020; 21(5): 479-483, doi: 10.1038/s41590-020-0648-y

21. Borghesi A. Life-threatening infections in human newborns: Reconciling age-specific vulnerability and interindividual variability. Cell Immunol. 2024: 397-398: 104807, doi: 10.1016/j.cellimm.2024.104807

22. Tharumakunarajah R., Lee A., Hawcutt D.B., Harman N.L., Sinha I.P. The Impact of Malnutrition on the Developing Lung and Long-Term Lung Health: A Narrative Review of Global Literature. Pulm Ther. 2024; 10(2): 155-170, doi: 10.1007/s41030-024-00257-z

23. Ibrahim M.K., Zambruni M., Melby C.L., Melby P.C. Impact of Childhood Malnutrition on Host Defense and Infection. Clin Microbiol Rev. 2017; 30(4): 919-971, doi: 10.1128/CMR.00119-16

24. Zhang Q., Bastard P., Liu Z., Le Pen J., Moncada-Velez M., et al. Inborn errors of type I IFN immunity in patients with life-threatening COVID-19. Science 2020; 370(6515): eabd4570, doi: 10.1126/science.abd4570

25. Mehta S., Shin H., Burnett R., North T., Cohen A.J. Ambient particulate air pollution and acute lower respiratory infections: a systematic review and implications for estimating the global burden of disease. Air Qual Atmos Health. 2013; 6(1): 69-83, doi: 10.1007/s11869-011-0146-3

26. Borisova O.V., Vjal'ceva V.A., Frank A.A. Dolgosrochnye nevrologicheskie posledstvija citomegalovirusnoj infekcii, perenesennoj v rannem neonatal'nom periode (obzor literatury). [Long-term neurological consequences of cytomegalovirus infection in the early neonatal period (literature review).] Prakticheskaja medicina [Practical Medicine] 2022; 20(7): 34-40. (In Russ.)

27. Gadroen K., Dodd C.N., Masclee G.M.C., de Ridder M.A.J., Weibel D., et al. Impact and longevity of measles-associated immune suppression: a matched cohort study using data from the THIN general practice database in the UK. BMJ Open. 2018; 8(11): e021465, doi: 10.1136/bmjopen-2017-021465

28. Netea M.G., Domínguez-Andrés J., Barreiro L.B., Chavakis T., Divangahi M., et al. Defining trained immunity and its role in health and disease. Nat Rev Immunol. 2020; 20(6): 375-388, doi: 10.1038/s41577-020-0285-6

29. Consiglio C.R., Cotugno N., Sardh F., Pou C., Amodio D., et al. The Immunology of Multisystem Inflammatory Syndrome in Children with COVID-19. Cell 2020; 183(4): 968-981.e7, doi: 10.1016/j.cell.2020.09.016

30. Swedo S.E., Leonard H.L., Garvey M., Mittleman B., Allen A.J., et al. Pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections: clinical description of the first 50 cases. Am J Psychiatry. 1998; 155(2): 264-271, doi: 10.1176/ajp.155.2.264

31. Gonzalez H., Khademi M., Andersson M., Wallström E., Borg K., et al. Prior poliomyelitis-evidence of cytokine production in the central nervous system. J Neurol Sci. 2002; 205(1): 9-13, doi: 10.1016/s0022-510x(02)00316-7

32. Armangue T., Spatola M., Vlagea A., Mattozzi S., Cárceles-Cordon M., et al. Frequency, symptoms, risk factors, and outcomes of autoimmune encephalitis after herpes simplex encephalitis: a prospective observational study and retrospective analysis. Lancet Neurol. 2018; 17(9): 760-772, doi: 10.1016/S1474-4422(18)30244-8

33. Fernández-Castañeda A., Lu P., Geraghty A.C., Song E., Lee M.H., et al. Mild respiratory COVID can cause multi-lineage neural cell and myelin dysregulation. Cell 2022; 185(14): 2452-2468.e16, doi: 10.1016/j.cell.2022.06.008

34. Geravandi S., Liu H., Maedler K. Enteroviruses and T1D: Is It the Virus, the Genes or Both which Cause T1D. Microorganisms. 2020; 8(7): 1017, doi: 10.3390/microorganisms8071017

35. Quinn L.M., Wong F.S., Narendran P. Environmental Determinants of Type 1 Diabetes: From Association to Proving Causality. Front Immunol. 2021; 12:737964, doi: 10.3389/fimmu.2021.737964

36. Esser N., Legrand-Poels S., Piette J., Scheen A.J., Paquot N. Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes. Diabetes Res Clin Pract. 2014; 105(2): 141-150, doi: 10.1016/j.diabres.2014.04.006

37. Dinleyici E.C., Dogruel N., Dinleyici M., Us T. Adrenal insufficiency associated with cytomegalovirus infection in two infants. Int J Infect Dis. 2009; 13(4): e181-4, doi: 10.1016/j.ijid.2008.08.021

38. Tomer Y. Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics. Annu Rev Pathol. 2014; 9: 147-56, doi: 10.1146/annurev-pathol-012513-104713

39. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., et al. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch Gen Psychiatry. 2004; 61(8): 774-780, doi: 10.1001/archpsyc.61.8.774

40. Parent C., Pokhvisneva I., Gaudreau H., Meaney M.J., Silveira P.P. Association Between Repeated Episodes of Gastroenteritis and Mental Health Problems in Childhood and Adolescence. J Am Acad Child Adolesc Psychiatry 2019; 58(11): 1115-1123, doi: 10.1016/j.jaac.2019.01.007

41. Savitz J. The kynurenine pathway: a finger in every pie. Mol Psychiatry. 2020; 25(1): 131-147, doi: 10.1038/s41380-019-0414-4

42. Ou W., Chen Y., Ju Y., Ma M., Qin Y., et al. The kynurenine pathway in major depressive disorder under different disease states: A systematic review and meta-analysis. J Affect Disord. 2023; 339: 624-632, doi: 10.1016/j.jad.2023.07.078

43. Guerra F.M., Bolotin S., Lim G., Heffernan J., Deeks S.L., et al. The basic reproduction number (R(0)) of measles: a systematic review. Lancet Infect Dis. 2017;17(12): e420-e428, doi: 10.1016/S1473-3099(17)30307-9

44. Abad C.L., Safdar N. The Reemergence of Measles. Curr Infect Dis Rep. 2015; 17(12): 51, doi: 10.1007/s11908-015-0506-5

45. Bhargavi G., Subbian S. The causes and consequences of trained immunity in myeloid cells. Front Immunol. 2024; 15: 1365127, doi: 10.3389/fimmu.2024.1365127

46. Jain R., Aulakh R. Measles-Associated CNS Complications: A Review. Journal of Child Science. 2022; 12(01): e172-181, doi: 10.1055/s-0042-1757914

47. Garon J.R., Cochi S.L., Orenstein W.A. The Challenge of Global Poliomyelitis Eradication. Infect Dis Clin North Am. 2015; 29(4): 651-665, doi: 10.1016/j.idc.2015.07.003

48. Li Hi Shing S., Chipika R.H., Finegan E., Murray D., Hardiman O., et al. Post-polio Syndrome: More Than Just a Lower Motor Neuron Disease. Front Neurol. 2019; 10: 773, doi: 10.3389/fneur.2019.00773

49. Odumade O.A., Hogquist K.A., Balfour H.H. Progress and Problems in Understanding and Managing Primary Epstein-Barr Virus Infections. Clin Microbiol Rev. 2011; 24(1): 193-209, doi: 10.1128/CMR.00044-10

50. Lanz T.V., Brewer R.C., Ho P.P., Moon J.S., Jude K.M., et al. Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAM. Nature 2022; 603(7900): 321-327, doi: 10.1038/s41586-022-04432-7

51. Hedström A.K. Risk factors for multiple sclerosis in the context of Epstein-Barr virus infection. Front Immunol. 2023; 14: 1212676, doi: 10.3389/fimmu.2023.1212676

52. Luo Y., Liu Y., Wang C., Gan R. Signaling pathways of EBV-induced oncogenesis. Cancer Cell Int. 2021; 21(1): 93, doi: 10.1186/s12935-021-01793-3

53. Menegatti J., Schub D., Schäfer M., Grässer F.A., Ruprecht K. HLA-DRB1*15:01 is a co-receptor for Epstein-Barr virus, linking genetic and environmental risk factors for multiple sclerosis. Eur J Immunol. 2021; 51(9): 2348-2350, doi: 10.1002/eji.202149179

54. Escalante G.M., Mutsvunguma L.Z., Muniraju M., Rodriguez E., Ogembo J.G. Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective. Front Immunol. 2022; 13:867918, doi: 10.3389/fimmu.2022.867918

55. Haunhorst S., Bloch W., Wagner H., Ellert C., Krüger K., et al. Long COVID: a narrative review of the clinical aftermaths of COVID-19 with a focus on the putative pathophysiology and aspects of physical activity. Oxf Open Immunol. 2022; 3(1): iqac006, doi: 10.1093/oxfimm/iqac006

56. McMillan P., Dexhiemer T., Neubig R.R.., Uhal B.D. COVID-19-A Theory of Autoimmunity Against ACE-2 Explained. Front Immunol. 2021; 12: 582166, doi: 10.3389/fimmu.2021.582166

57. Sansone F., Pellegrino G.M., Caronni A., Bonazza F., Vegni E., et al. Long COVID in Children: A Multidisciplinary Review. Diagnostics (Basel) 2023; 13(12): 1990, doi: 10.3390/diagnostics13121990

58. Asghar Z., Sharaf K., Butt F.A., Shaikh O.A., Shekha M., et al. A global review of racial, ethnic and socio-economic disparities in multisystem inflammatory syndrome in children related to COVID-19. Front Public Health. 2022; 10: 996311, doi: 10.3389/fpubh.2022.996311

59. Yousaf A.R., Miller A.D., Lindsey K., Shah A.B., Wu M.J., et al. Multisystem Inflammatory Syndrome in Children Among Persons Who Completed a Two-dose COVID-19 Vaccine Primary Series Compared with Those Reporting No COVID-19 Vaccination, US National MIS-C Surveillance. Pediatr Infect Dis J. 2023; 42(12): e476-e478, doi: 10.1097/INF.0000000000004103

60. Dhalaria P., Kumar P., Verma A., Priyadarshini P., Singh A.K., et al. Exploring landscape of measles vaccination coverage: A step towards measles elimination goal in India. Vaccine. 2024; 42(17): 3637-3646, doi: 10.1016/j.vaccine.2024.04.075

61. Wonodi C., Farrenkopf B.A. Defining the Zero Dose Child: A Comparative Analysis of Two Approaches and Their Impact on Assessing the Zero Dose Burden and Vulnerability Profiles across 82 Low- and Middle-Income Countries. Vaccines (Basel) 2023; 11(10): 1543, doi: 10.3390/vaccines11101543

62. Wang Y., Wei X., Liu Y., Li S., Pan W., et al. Towards broad-spectrum protection: the development and challenges of combined respiratory virus vaccines. Front Cell Infect Microbiol. 2024; 14: 1412478, doi: 10.3389/fcimb.2024.1412478

63. Rahman A.E., Mhajabin S., Dockrell D., Nair H., El Arifeen S., et al. Managing pneumonia through facility-based integrated management of childhood management (IMCI) services: an analysis of the service availability and readiness among public health facilities in Bangladesh. BMC Health Serv Res. 2021; 21(1): 667, doi: 10.1186/s12913-021-06659-y

64. Billah S.M., Raihana S., Ali N.B., Iqbal A., Rahman M.M., et al. Bangladesh: a success case in combating childhood diarrhoea. J Glob Health. 2019; 9(2): 020803, doi: 10.7189/jogh.09.020803

65. Akello A.R., Byagamy J.P., Etajak S., Okadhi C.S., Yeka A. Factors influencing consistent use of bed nets for the control of malaria among children under 5 years in Soroti District, North Eastern Uganda. Malar J. 2022; 21(1): 363, doi: 10.1186/s12936-022-04396-z